• Oral CXCR4 Antagonism in WHIM Syndrome: Phase 3 Clinical Ins

  2026-07-23

  A recent phase 3 trial demonstrates that mavorixafor, an oral CXCR4 antagonist, significantly improves neutrophil and lymphocyte counts and reduces infection rates in WHIM syndrome. This work marks an advance over prior therapies by directly targeting the molecular defect, with a manageable safety profile and practical oral dosing.

• Annexin V-FITC/7-AAD Apoptosis Kit: Precision in Apoptosis R

  2026-07-22

  Explore the scientific foundations and advanced applications of the Annexin V-FITC/7-AAD Apoptosis Kit for apoptosis and cell viability analysis. Discover how innovative assay strategies and insights from protein bioactivity research elevate experimental outcomes.

• AS1842856 Foxo1 Inhibitor: Experimental Workflows & Optimiza

  2026-07-22

  AS1842856, a potent Foxo1 inhibitor, enables precise modulation of metabolic and stem cell pathways central to autophagy and gluconeogenesis research. This guide translates new mechanistic insight into actionable protocols for metabolic disease and bone remodeling studies, including advanced troubleshooting and workflow customization.

• Mitochondrial Calcium Signaling Suppresses Ferroptosis via G

  2026-07-21

  This study uncovers how mitochondrial calcium uptake via the MCU channel safeguards cells from ferroptotic death by promoting acetylation and activity of GPX4, a crucial enzyme in lipid peroxidation control. The findings provide a mechanistic bridge between mitochondrial metabolism, calcium signaling, and ferroptosis sensitivity, with substantial implications for cancer and acute injury research.

• JEV-Induced Lysosomal Dysfunction via LAMP1/2 Downregulation

  2026-07-21

  This study reveals how Japanese Encephalitis Virus (JEV) impairs lysosomal function by downregulating LAMP1 and LAMP2 proteins through the viral NS4B protein, leading to altered autophagic and antigen presentation pathways. These findings offer mechanistic insight relevant for virology, immunology, and autophagy research.

• AR and ARv7 in TNBC: Prognostic Significance and EPI-001 Blo

  2026-07-20

  This study demonstrates that androgen receptor (AR) and its splice variant ARv7 are independent poor prognostic factors in triple-negative breast cancer (TNBC), correlating with increased metastasis and reduced survival. Importantly, the research reveals that targeting AR/ARv7 with N-terminal domain inhibitors, particularly EPI-001, disrupts metastatic and epithelial-mesenchymal transition (EMT) pathways in TNBC models.

• Bifendate Inhibits Autophagy and Reduces Lipid Droplet Accum

  2026-07-20

  This study reveals that bifendate (DDB), a clinically used hepatoprotective agent, disrupts multiple steps in autophagy and thereby reduces oleic acid-induced lipid droplet accumulation in vitro. These findings clarify DDB's role in hepatic lipid metabolism and offer mechanistic insights for research on autophagy-related liver diseases.

• Polymyxin B Sulfate: Advanced Workflows for MDR Infection Re

  2026-07-19

  Leverage the unique membrane-disrupting and immunomodulatory properties of Polymyxin B (sulfate) to overcome multidrug resistance in Gram-negative bacterial infection models. This guide details actionable protocols and troubleshooting strategies for maximizing assay sensitivity, reproducibility, and translational relevance.

• Deferiprone: Precision Iron Chelation for Advanced Cell Stud

  2026-07-18

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) empowers researchers to dissect iron-dependent cellular pathways with unprecedented specificity. Its aqueous solubility and proven efficacy in modulating apoptosis and metabolic reprogramming set it apart for cancer biology and enterocyte metabolism research.

• IL-1β/NF-κB Regulation of ACE2 Drives Macrophage SARS-CoV-2

  2026-07-17

  Lee et al. delineate a mechanism by which IL-1β-induced NF-κB activation upregulates ACE2 in lung macrophages, facilitating their infection by SARS-CoV-2. Their development of a humanized ACE2 mouse model refines our understanding of COVID-19 pathogenesis and has implications for studying host resilience and severity factors.

• Translatome Remodeling Links Dietary Fatty Acids to Tumorige

  2026-07-17

  This study reveals how fasting and ketogenic diets trigger selective translation of lipid metabolism genes via a novel AMPK-MNK-eIF4E signaling axis in hepatocytes, impacting ketogenesis and pancreatic tumor growth. The findings illuminate fatty acid-driven translational control as a crucial mechanism connecting dietary interventions to cancer vulnerability.

• SP600125: Redefining JNK Inhibition for Translational Scienc

  2026-07-16

  Explore a strategic, mechanistically-driven perspective on SP600125, a highly selective JNK inhibitor, and its transformative applications in apoptosis, inflammation, and neuropathic pain research. This thought-leadership article bridges advanced mechanistic insight with actionable experimental guidance, supported by new findings and a comparative landscape.

• Yeast-Engineered Exendin-4 for Accessible Type 2 Diabetes Re

  2026-07-16

  This study demonstrates stable chromosomal expression of Exendin-4 in Saccharomyces cerevisiae, providing a foundation for cost-effective, locally produced GLP-1 receptor agonists. The approach addresses critical barriers in diabetes medication accessibility and has implications for beta cell function and insulin sensitivity research workflows.

• Primidone (Mysoline) in Translational Neurobiology: Protocol

  2026-07-15

  Primidone (Mysoline) is redefining translational neurobiology with its dual targeting of TRPM3 and RIPK1, enabling robust workflows in neurodegenerative and gynecological models. This article delivers protocol enhancements, troubleshooting strategies, and practical insights for maximizing experimental impact with APExBIO's Primidone.

• HOBt (1-Hydroxybenzotriazole): Precision in Peptide Synthesi

  2026-07-15

  HOBt (1-Hydroxybenzotriazole) is an essential racemization inhibitor, enabling high-fidelity amide bond formation and unlocking advanced peptide and antibiotic derivative workflows. Discover stepwise protocols, troubleshooting insights, and how this APExBIO reagent elevates modern medicinal chemistry.

445 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page